HAIVYA reports 120.9% yield jump in third-party cannabis trial

HAIVYA says an independent trial of its sound-based BCCP protocol produced major gains in cannabis yield, water efficiency and crop uniformity in a 36-plant study run from December 2025 through March 2026. The company is now lining up more validation work this summer, including studies on rooting propagation, cross-species response and larger commercial cultivation. Why it matters: - HAIVYA is pitching BCCP as a non-chemical, non-genetic input layer for precision agriculture. - The trial results, if repeatable, could point to higher output with less water and more predictable crop timing. - The findings matter for cannabis operators because the study links yield gains to unchanged THC potency and improved uniformity. What happened: - HAIVYA announced results from an independent third-party validation trial of its Bioacoustic Cultivation and Communication Protocol, or BCCP. - The controlled cultivation study ran from December 2025 through March 2026. - The trial covered 36 Cannabis sativa L. plants. - Robert Flannery, Ph.D., founder of Dr. Robb Farms and a UC Davis alumnus, authored the white paper. - Pure Cannalyst Labs in Irvine, California, independently verified cannabinoid and terpene profiles. - HAIVYA is also pointing readers to the full white paper through its Research & Validation page. The details: - BCCP-treated plants produced a 120.9% increase in trimmed bud weight, rising from 12.8 grams to 28.2 grams per plant. - Total harvestable dry flower increased 92.4%, from 30.7 grams to 59.0 grams per plant. - Water input fell 34.7% per gram of output. - Crop uniformity improved, with the coefficient of variation in trimmed bud weight dropping from 58.8% in controls to 35.6% in BCCP-treated plants. - Weight per trimmed budsite rose 57.1%, from 225 mg to 354 mg. - The flower-waste ratio was statistically equivalent between groups. - All BCCP-treated plants initiated pre-flower development before photoperiod transition, compared with 5.6% of controls. - Total THC by weight increased 119.5% per plant, from 3.20 grams to 7.03 grams. - THC potency stayed statistically equivalent at 24.90% for BCCP plants and 25.05% for controls. - Terpene concentration rose 4.6%, with beta-caryophyllene up 22.4%. - HAIVYA says BCCP is not a spray, supplement, seed trait, genetic modification, or chemical growth regulator. - The protocol uses phased acoustic exposure at defined stages of plant development. - HAIVYA says the approach is designed to engage plant mechanosensory response pathways tied to touch, wind and vibration. - The BCCP platform is the subject of a non-provisional patent application and multiple supporting provisionals covering agricultural applications and the underlying biological approach. Between the lines: - The study isolates one variable: exposure to the BCCP acoustic protocol. - Cultivation conditions were held consistent between treated and control groups. - The combination of higher yield, lower water use and unchanged potency is the main commercial claim here. - Dr. Flannery said the result is worthy of follow-up because it appeared to affect several commercial metrics at once without fertilizers, chemicals, genetic modification or other conventional inputs. - Keston Ott-Dahl, HAIVYA co-founder and COO, said the company sees the result as part of a broader pattern across trials and species and wants to test repeatability across rooms, cultivars, facilities and plant species. What’s next: - HAIVYA expects Dr. Flannery’s white paper to be the first in a broader validation sequence it plans to release this summer. - The company says additional work is underway on a third-party rooting propagation study led by Dr. Alison Justice at an unaffiliated site in South Carolina. - HAIVYA also plans to release Andrea Ott-Dahl’s cross-species BCCP response white paper. - A larger commercial cultivation study is under way under a formal research agreement with Dr. Robb Farms. The bottom line: - HAIVYA is trying to turn a sound-based plant protocol into a repeatable agricultural product, and the next round of validation will determine whether this first cannabis study is a one-off or a scalable result.